NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

WSJ "Research Report" column is a real gem

Posted By

Tags

Every two weeks, the Wall Street Journal publishes a terrific column by Jeremy Singer-Vine. Each column gives a brief synopsis of a recent research story and then gives readers caveats about or limitations in the study itself.

It’s exactly the kind of breakdown that more journalists should do every day when they cover medical research news.

Here is his latest column.

He commonly cautions readers about not drawing conclusions because of:

• lack of long-term data
• small study size
• drop out rates in the trial should be taken into account
• research done in animals not humans
• research that was observational, not a true experiment
• research that can only point to statistical association, not causation
• confounding factors that may explain what was seen in the study
• results may not be generalizable to other populations
• result may not be generalizable to other similar products

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.